These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 23216549)

  • 1. Withdrawal of generic budeprion for nonbioequivalence.
    Woodcock J; Khan M; Yu LX
    N Engl J Med; 2012 Dec; 367(26):2463-5. PubMed ID: 23216549
    [No Abstract]   [Full Text] [Related]  

  • 2. Wellbutrin versus generic bupropion.
    Med Lett Drugs Ther; 2008 Jul; 50(1290):54-5. PubMed ID: 18617874
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug Administration.
    Davit BM; Nwakama PE; Buehler GJ; Conner DP; Haidar SH; Patel DT; Yang Y; Yu LX; Woodcock J
    Ann Pharmacother; 2009 Oct; 43(10):1583-97. PubMed ID: 19776300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the bioavailability and bioequivalence of generic medications.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2010 Jan; 48(1):13-6. PubMed ID: 20102127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. United States Food and Drug Administration requirements for approval of generic drug products.
    Meyer MC
    J Clin Psychiatry; 2001; 62 Suppl 5():4-9; discussion 23-4. PubMed ID: 11305846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deficiencies of the FDA in evaluating generic formulations: addressing narrow therapeutic index drugs.
    Hottinger M; Liang BA
    Am J Law Med; 2012; 38(4):667-89. PubMed ID: 23356099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In U.S., biosimilars still await FDA decision.
    Finkelstein JB
    J Natl Cancer Inst; 2006 Apr; 98(7):435. PubMed ID: 16595775
    [No Abstract]   [Full Text] [Related]  

  • 8. What's the problem with generic antiepileptic drugs?: a call to action.
    Berg MJ
    Neurology; 2007 Apr; 68(16):1245-6. PubMed ID: 17438211
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of the bioequivalence of generic versus branded clozapine.
    Ereshefsky L; Glazer WM
    J Clin Psychiatry; 2001; 62 Suppl 5():25-7. PubMed ID: 11305845
    [No Abstract]   [Full Text] [Related]  

  • 10. The generic drug approval process.
    Rheinstein PH
    Am Fam Physician; 1993 Dec; 48(8):1357-60. PubMed ID: 8249762
    [No Abstract]   [Full Text] [Related]  

  • 11. Generic drugs.
    Gross D
    Issue Brief (Public Policy Inst (Am Assoc Retired Pers)); 2003 May; (IB61):1-18. PubMed ID: 12807116
    [No Abstract]   [Full Text] [Related]  

  • 12. In brief: Budeprion XL has been withdrawn.
    Med Lett Drugs Ther; 2012 Oct; 54(1402):88. PubMed ID: 23114740
    [No Abstract]   [Full Text] [Related]  

  • 13. The need for additional metrics to assess therapeutic equivalence of some multiphasic modified-release products.
    Kondra PM; Endrenyi L; Tothfalusi L
    Clin Ther; 2011 Sep; 33(9):1214-9. PubMed ID: 21849209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Food and Drug Administration and patent law at a crossroads: the listing of polymorph patents as a barrier to generic drug entry.
    Srivastava D
    Food Drug Law J; 2004; 59(2):339-54. PubMed ID: 15298015
    [No Abstract]   [Full Text] [Related]  

  • 15. When is a "generic" medication not really a generic?
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2010 Feb; 48(2):13-6. PubMed ID: 20166651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is generic really the same?
    Behav Healthc Tomorrow; 2001 Feb; 10(1):31-2. PubMed ID: 11216062
    [No Abstract]   [Full Text] [Related]  

  • 17. What makes a generic medication generic?
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2009 Dec; 47(12):17-20. PubMed ID: 20000278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generic drugs: an overview.
    Helgeland D
    S D Med; 2006 Apr; 59(4):161-3. PubMed ID: 16681165
    [No Abstract]   [Full Text] [Related]  

  • 19. The effectiveness of generic agents in psychopharmacologic treatment.
    Kumet R; Gelenberg AJ
    Essent Psychopharmacol; 2005; 6(2):104-11. PubMed ID: 15765794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial responses to recommendations of the Blue Ribbon Committee on Generic Medicines.
    Heller WM
    Am J Hosp Pharm; 1993 Feb; 50(2):318-22. PubMed ID: 8480792
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.